April 12, 2022
Dirix L et al. Breast Cancer Research and Treatments, 2022
Circulating tumor cell detection: A prospective comparison between CellSearch® and RareCyte® platforms in patients with progressive metastatic breast cancer
You might also be interested by
Posters
Monitoring M-Protein Levels in Multiple Myeloma Using Microsampling Devices Coupled With Intact Mass High-Resolution Mass Spectrometry
November 19, 2024
More infoPosters
Accelerating analysis of cytometry data sets leveraging a visualization tool built within CellEngine, a cloud-based cytometry analysis software
November 7, 2024
More infoPosters
Analyzing CITE-seq data like an immunologist with a hybrid hierarchical gating approach in CellEngine software
October 29, 2024
More infoBrochures & Infographics
Biomarker Strategies for Cell Therapy in Autoimmune Diseases Measuring the B Cell Reset
October 16, 2024
More info